Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock”

Okay, I had Recursion on when they were 9, 10. They did an equity offering. The stock got clobbered. It’s been down.
NAI500

Nvidia-Backed AI Biotech Recursion Soars 25% in a Month: Time to Buy or Beware?

Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down ...
IEEE

Modified Sigmoid Function-Based Proportionate Diffusion Recursive Adaptive Filtering Algorithm Over Sensor Network

Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...